Sponsored session - Save Your Skin : from skin cancer detection to improving patient’s quality of life

Sponsored session - Save Your Skin : from skin cancer detection to improving patient’s quality of life

Room 8 (level 0)
Sponsored session

Information

Session organised by La Roche-Posay

Chaired by Steven McIntosh, Macmillan Cancer Support (United Kingdom)

Presentations:

1. Panel discussion - Samir Salah, La Roche-Posay (France)

2. Panel discussion - Delphine Kerob, La Roche Posay Laboratoire Dermatologique (France)

3. Panel discussion - Erik De Heus, SkinVision BV (France)

Theme
1. Prevention, screening and early detection
Objectives
The World Health Organization (WHO) estimates that approximately 1.5 million new cases of skin cancer occurred in 2020, of which approximately 325,000 cases were melanoma, resulting in 57,043 deaths. Non melanoma skin cancers (NMSC), despite lower mortality likelihood, led to 63,731 deaths in 2020 due to significantly higher incidence.Skin cancer detection plays a crucial role in improving patient's outcomes including disease-free and overall survivals, as well as quality of life by enabling early diagnosis and treatment. . Additionally, regular skin cancer awareness campaigns can help individuals stay informed about their health and take proactive steps to protect themselves from harmful UV exposure. This can include encouraging wearing protective clothing, hats and sunglasses, seeking shade during peak sun hours, avoiding indoor tanning, and using sunscreen on uncovered areas.Overall, by combining efforts in skin cancer detection, treatment, prevention, and support, healthcare professionals can make a significant impact on improving patient's quality of life and reducing the burden of skin cancer on individuals and society as a whole.ls to be added soon
La Roche-PosayN°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. Recommended by 90,000 dermatologists worldwide*, La Roche-Posay was created by a pharmacist in 1975. The brand is today present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water, also used at its Thermal Center, the first Dermatology Center in Europe, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin. The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer specifically. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare. Since 2019, the Fondation La Roche-Posay is also committed to improving the life of children with cancer and their families. In 2020, the brand went a step further in its commitment to protect the planet. Besides launching the first eco-designed tubes integrating cardboard, the brand announced a long-term plan to reduce its use of virgin plastic by 70% in 2025. For additional information about La Roche-Posay, visit www.laroche-posay.com. *source: survey on the dermocosmetic market carried out by iqvia and other partners (ipsos, tns) between september 2017 and august 2018 among dermatologists in 62 countries.

Log in